Skip to content

The Radiation Oncology Registry and Biosample Repository

Registry and Biosample Repository

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01577251
Enrollment
8000
Registered
2012-04-13
Start date
2008-06-01
Completion date
2030-12-01
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasia

Brief summary

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Interventions

None listed

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy * Able to sign consent

Design outcomes

Primary

MeasureTime frame
Health Assessments10 years

Countries

United States

Contacts

CONTACTProject Manager
radonccru@pennmedicine.upenn.edu
PRINCIPAL_INVESTIGATORJay Dorsey, MD, PhD

University of Pennsylvania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026